|
1
|
Zhang Y, Wang S, Li D, et al: A systems
biology-based classifier for hepatocellular carcinoma diagnosis.
PloS One. 6:e224262011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Almogy G, Lieberman S, Gips M, et al:
Clinical outcomes of surgical resections for primary liver sarcoma
in adults: results from a single centre. Eur J Surg Oncol.
30:421–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tanaka S and Arii S: Molecularly targeted
therapy for hepatocellular carcinoma. Cancer Sci. 100:1–8. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Noteborn MH, Todd D, Verschueren CA, et
al: A single chicken anemia virus protein induces apoptosis. J
Virol. 68:346–351. 1994.PubMed/NCBI
|
|
5
|
Noteborn MH, de Boer GF, van Roozelaar DJ,
et al: Characterization of cloned chicken anemia virus DNA that
contains all elements for the infectious replication cycle. J
Virol. 65:3131–3139. 1991.PubMed/NCBI
|
|
6
|
Tavassoli M, Guelen L, Luxon BA and Gaken
J: Apoptin: specific killer of tumor cells? Apoptosis. 10:717–724.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noteborn MH: Proteins selectively killing
tumor cells. Eur J Pharmacol. 625:165–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guelen L, Paterson H, Gaken J, Meyers M,
Farzaneh F and Tavassoli M: TAT-apoptin is efficiently delivered
and induces apoptosis in cancer cells. Oncogene. 23:1153–1165.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Danen-Van Oorschot AA, Fischer DF,
Grimbergen JM, et al: Apoptin induces apoptosis in human
transformed and malignant cells but not in normal cells. Proc Natl
Acad Sci USA. 94:5843–5847. 1997.PubMed/NCBI
|
|
10
|
Danen-Van Oorschot AA, Zhang YH, Leliveld
SR, et al: Importance of nuclear localization of apoptin for
tumor-specific induction of apoptosis. J Biol Chem.
278:27729–27736. 2003.PubMed/NCBI
|
|
11
|
Heilman DW, Teodoro JG and Green MR:
Apoptin nucleocytoplasmic shuttling is required for cell
type-specific localization, apoptosis, and recruitment of the
anaphase-promoting complex/cyclosome to PML bodies. J Virol.
80:7535–7545. 2006. View Article : Google Scholar
|
|
12
|
Maddika S, Wiechec E, Ande SR, et al:
Interaction with PI3-kinase contributes to the cytotoxic activity
of apoptin. Oncogene. 27:3060–3065. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maddika S, Bay GH, Kroczak TJ, et al: Akt
is transferred to the nucleus of cells treated with apoptin, and it
participates in apoptin-induced cell death. Cell Prolif.
40:835–848. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang J, Cole D, Westwood N, et al:
Crucial roles for protein kinase C isoforms in tumor-specific
killing by apoptin. Cancer Res. 70:7242–7252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Teodoro JG, Heilman DW, Parker AE and
Green MR: The viral protein Apoptin associates with the
anaphase-promoting complex to induce G2/M arrest and apoptosis in
the absence of p53. Genes Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Janssen K, Hofmann TG, Jans DA, Hay RT,
Schulze-Osthoff K and Fischer U: Apoptin is modified by SUMO
conjugation and targeted to promyelocytic leukemia protein nuclear
bodies. Oncogene. 26:1557–1566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi L, Nishioka WK, Th’ng J, Bradbury EM,
Litchfield DW and Greenberg AH: Premature p34cdc2 activation
required for apoptosis. Science. 263:1143–1145. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuusisto HV, Wagstaff KM, Alvisi G and
Jans DA: The C-terminus of apoptin represents a unique tumor
cell-enhanced nuclear targeting module. Int J Cancer.
123:2965–2969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murray AW: Recycling the cell cycle:
cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brown NR, Noble ME, Endicott JA and
Johnson LN: The structural basis for specificity of substrate and
recruitment peptides for cyclin-dependent kinases. Nat Cell Biol.
1:438–443. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Loog M and Morgan DO: Cyclin specificity
in the phosphorylation of cyclin-dependent kinase substrates.
Nature. 434:104–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brotherton DH, Dhanaraj V, Wick S, et al:
Crystal structure of the complex of the cyclin D-dependent kinase
Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature.
395:244–250. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jeffrey PD, Russo AA, Polyak K, et al:
Mechanism of CDK activation revealed by the structure of a
cyclinA-CDK2 complex. Nature. 376:313–320. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Honda R, Lowe ED, Dubinina E, et al: The
structure of cyclin E1/CDK2: implications for CDK2 activation and
CDK2-independent roles. EMBO J. 24:452–463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Los M, Panigrahi S, Rashedi I, et al:
Apoptin, a tumor-selective killer. Biochim Biophys Acta.
1793:1335–1342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maddika S, Panigrahi S, Wiechec E, et al:
Unscheduled Akt-triggered activation of cyclin-dependent kinase 2
as a key effector mechanism of apoptin’s anticancer toxicity. Mol
Cell Biol. 29:1235–1248. 2009.PubMed/NCBI
|
|
27
|
Golsteyn RM: Cdk1 and Cdk2 complexes
(cyclin dependent kinases) in apoptosis: a role beyond the cell
cycle. Cancer Lett. 217:129–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee YH, Cheng CM, Chang YF, Wang TY and
Yuo CY: Apoptin T108 phosphorylation is not required for its
tumor-specific nuclear localization but partially affects its
apoptotic activity. Biochem Biophys Res Commun. 354:391–395. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Poon IK, Oro C, Dias MM, Zhang J and Jans
DA: Apoptin nuclear accumulation is modulated by a CRM1-recognized
nuclear export signal that is active in normal but not in tumor
cells. Cancer Res. 65:7059–7064. 2005. View Article : Google Scholar : PubMed/NCBI
|
